Treace Medical Concepts, Inc. (TMCI) Misses Q2 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $30 million versus the consensus estimate of $28.63 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
• XP Inc. (XP) Tops Q2 EPS by 8c